Application of FAPI PET/CT in peritoneal carcinomatosis
10.3760/cma.j.cn321828-20230620-00180
- VernacularTitle:FAPI PET/CT在腹膜转移癌中的应用
- Author:
Qiao CHEN
1
;
Guangming LI
Author Information
1. 广州医科大学附属清远医院（清远市人民医院）影像中心，清远 511518
- Keywords:
Neoplasm metastasis;
Peritoneum;
Antagonists and inhibitors;
Membrane proteins;
Fibroblasts;
Positron-emission tomography;
Tomography, X-ray computed
- From:
Chinese Journal of Nuclear Medicine and Molecular Imaging
2024;44(8):509-512
- CountryChina
- Language:Chinese
-
Abstract:
The patient survival rate of peritoneal carcinomatosis can be significantly improved by aggressive treatment. Imaging examination is crucial for clinical diagnosis and treatment of this disease. Fibroblast activation protein inhibitor (FAPI) PET/CT, as a hotspot of nuclear medicine research, provides a new way for the diagnosis of peritoneal carcinomatosis. This review summarizes the application of FAPI PET/CT in the diagnosis of peritoneal carcinomatosis, including the diagnostic value and limitations.
